Quality of life with cediranib in relapsed ovarian cancer: the ICON6 phase 3 randomised clinical trial
- Submitting institution
-
The University of Leeds
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- UOA2-710
- Type
- D - Journal article
- DOI
-
10.1002/cncr.30657
- Title of journal
- Cancer
- Article number
- -
- First page
- 2752
- Volume
- 123
- Issue
- 14
- ISSN
- 0008-543X
- Open access status
- Compliant
- Month of publication
- March
- Year of publication
- 2017
- URL
-
https://doi.org/10.1002/cncr.30657
- Supplementary information
-
-
- Request cross-referral to
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
10
- Research group(s)
-
-
- Citation count
- 13
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
